About Genomic Health Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth, Facebook, YouTube and LinkedIn.
About Oncotype DX® The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. With half a million patients tested in more than 80 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. To learn more about Oncotype DX tests, visit www.OncotypeDX.com, www.mybreastcancertreatment.org and www.myprostatecancertreatment.org.
Current Team (5)Update
Board Members and Advisors (3)Update
|Aug 10, 2016||google.com - Genomic Health Inc. (NASDAQ:GHDX) Fundamental Star Rating Report|
|Aug 1, 2016||SiliconBeat - Biz Break: Apple has 625.6 million reasons to be happy|
|Jun 22, 2016||PRNewswire All - Global Companion Diagnostics Market Analysis & Trends Report 2016-2025 - Growth Opportunities/Investment Opportunities - Research and Markets|
|Jun 20, 2016||Business Insider Australia - We asked healthcare leaders for their best career advice -- and what they shared applies beyond their industry|
|Jun 11, 2016||The Economist - On target|
|Jun 7, 2016||SiliconBeat - Biz Break: Twitter gets hit as NFL’s account gets hacked|
|Jun 7, 2016||PRNewswire UK All - Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2016-2019 - Research and Markets|
|Jun 6, 2016||SiliconBeat - Biz Break: Sheryl Sandberg, Susan Wojcicki, Meg Whitman among Forbes’ Most Powerful Women|
101 Galveston Drive
Redwood City, CA 94063